ArticleCureus2025
Wernicke's Encephalopathy Beyond Alcoholism: A Radio-Clinical Case Series From a Tertiary Care Center in South India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Wernicke's encephalopathy (WE) is a serious yet potentially reversible neurological condition resulting from thiamine (vitamin B1) deficiency. Although traditionally linked to chronic alcohol consumption, an increasing number of cases are now being recognized in nonalcoholic individuals, where atypical clinical presentations often lead to diagnostic challenges and delays in treatment. This case series highlights a spectrum of WE cases with varied underlying etiologies, along with their clinical manifestations and characteristic neuroimaging findings. By emphasizing the importance of early recognition and imaging, this study aims to increase clinical awareness and promote timely, appropriate management, thereby reducing morbidity and improving outcomes. Materials and methods This retrospective case series analyzed 14 patients diagnosed with WE between January 2020 and January 2025 at a tertiary care center in South India. The inclusion criteria were clinical suspicion of WE, with supportive MRI findings showing bilateral symmetrical T2/FLAIR hyperintensities in typical regions (thalami, mammillary bodies, and periaqueductal gray). Patients with alternative diagnoses were excluded. Clinical details, comorbidities, etiological factors, imaging findings, treatment response, and outcomes were reviewed. All patients received thiamine therapy. Descriptive statistics were used to summarize the data. Results Among the 14 patients, four were chronic alcoholics, while 10 had nonalcoholic causes such as hyperemesis gravidarum (3), nutritional deficiency (4), parenteral nutrition (2), and CKD on dialysis (1). Most patients presented with altered sensorium and incomplete classical triad symptoms. MRI consistently showed typical WE findings, with additional atypical sites in some nonalcoholic cases. Twelve patients improved with thiamine supplementation, while two were lost to follow-up. All pregnant patients had favorable obstetric outcomes. Conclusions WE is often underdiagnosed, especially in nonalcoholic patients, due to atypical presentations. Clinicians and radiologists should maintain a high index of suspicion for WE in patients with risk factors beyond alcohol use. Early diagnosis and treatment are critical to prevent irreversible neurological damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.